4-bromophenylboric acid has been researched along with benzeneboronic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baquero, F; Blázquez, J; Shoichet, BK; Weston, GS | 1 |
| Hall, RA; Innocenti, A; Mühlschlegel, FA; Scozzafava, A; Supuran, CT; Winum, JY | 1 |
| Kayastha, AM; Kumar, S | 1 |
| Belitsky, JM | 1 |
| Bouillon, A; Cresteil, T; Fontaine, F; Hequet, A; Jolivalt, C; Lesnard, A; Rault, S; Voisin-Chiret, AS | 1 |
5 other study(ies) available for 4-bromophenylboric acid and benzeneboronic acid
| Article | Year |
|---|---|
Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Boronic Acids; Crystallography, X-Ray; Drug Synergism; Enterobacter cloacae; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Structure-Activity Relationship; Thiophenes | 1998 |
Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids.
Topics: Boronic Acids; Candida albicans; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cryptococcus neoformans; Humans; Structure-Activity Relationship | 2009 |
Inhibition studies of soybean (Glycine max) urease with heavy metals, sodium salts of mineral acids, boric acid, and boronic acids.
Topics: Binding, Competitive; Boric Acids; Boron Compounds; Boronic Acids; Copper; Enzyme Inhibitors; Glycine max; Kinetics; Mercury; Metals, Heavy; Seeds; Silver; Sodium Fluoride; Urease | 2010 |
Aryl boronic acid inhibition of synthetic melanin polymerization.
Topics: Boronic Acids; Catechols; Levodopa; Melanins; Structure-Activity Relationship | 2010 |
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Boronic Acids; Cell Survival; Ciprofloxacin; Culture Media; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; KB Cells; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Structure-Activity Relationship | 2014 |